Phanes Therapeutics Revenue

Biotechnology Research • San Diego, California, United States • 21-50 Employees

Phanes Therapeutics revenue & valuation

Annual revenue	$2,300,000
Revenue per employee	$83,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,400,000
Total funding	$40,000,000

Key Contacts at Phanes Therapeutics

Mary Topalovski

Director, Business Development & Alliance Management

Satya Das

Executive Medical Director

Grace Mcgregor

Senior Director Of Clinical Development

Albert Lam

Director Of Process Development

Christina Sanchez

Associate Director Clinical Operations

Company overview

Headquarters	11535 Sorrento Valley Rd, Suite 400, San Diego, California 92121, US
Website	phanesthera.com
NAICS	541714
SIC	873
Founded	2016
Employees	21-50
Socials

Phanes Therapeutics Email Formats

Phanes Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@phanesthera.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@phanesthera.com	100%

About Phanes Therapeutics

Phanes Therapeutics, Inc. is a clinical stage biotech company focused on innovative drug discovery and development in oncology. Currently, it is conducting three Phase I clinical trials, including the MORNINGSTAR study with its best-in-class monoclonal antibody (mAb) program, PT199, the TWINPEAK study with PT886 and the SKYBRIDGE study with PT217. Both PT886 and PT217 are first-in-class bispecific antibodies and have been granted orphan drug designation as well as Fast Track designation by the FDA. The company has built a strong pipeline by leveraging its proprietary technology platforms: PACbody®, SPECpair® and ATACCbody® to develop novel biologics that address high unmet medical needs in cancer. For more information about Phanes Therapeutics, please visit www.phanesthera.com. For business development or media inquiries, please contact bd@phanestx.com or media@phanestx.com respectively.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

Manager

Employees by Department

Phanes Therapeutics has 12 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Phanes Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-06-07	5	$40,000,000
2024-02-01	1	N/A

Funding Insights

$40,000,000

Total funding amount

Number of funding rounds

Phanes Therapeutics Tech Stack

Discover the technologies and tools that power Phanes Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

SiteOrigin Page Builder

Page builders

MetaSlider

WordPress plugins

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

SiteOrigin Widgets Bundle

WordPress plugins

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Bootstrap

UI frameworks

Frequently asked questions

Phanes Therapeutics is located in San Diego, California, US.

Phanes Therapeutics generates an estimated annual revenue of $2,300,000. This revenue figure reflects the company's market position and business performance in its industry.

Phanes Therapeutics has an estimated valuation of $7,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Phanes Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Phanes Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Phanes Therapeutics has raised a total of $40,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.